Etomidate Injection is the generic version of Hospira’s Amidate Injection, which is an intravenous general anesthesia.
The newly-approved drug has begun shipping in the United States. Sales for the last 12 months of Etomidate Injection, ending in March, were $6.58 million.
More Articles on Anesthesia:
Colorado Society of Anesthesiologists ‘Dismayed’ at CRNA Ruling
Dr. Benjamin Rubin Joins Fox Chase Anesthesiology
FDA Issues Class 1 Recall for Maquet Anesthesia System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
